P1396: EFFICACY AND SAFETY COMPARISON OF CALCINEURIN INHIBITORS USED FOR GVHD PROPHYLAXIS IN HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH THALASSEMIA
Main Authors: | S. Zhumatayev, K. Yalcin, S. Celen, N. Azizova Gurbanzade, M. Mazen Jazazi, G. Tezcan, V. Uygun, M. A. Yesilipek |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-06-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/01.HS9.0000848444.21356.4d |
Similar Items
-
P1395: POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME AFTER PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: SINGLE-CENTER EXPERIENCE
by: S. Zhumatayev, et al.
Published: (2022-06-01) -
Utility of Procalcitonin in the Engraftment Phase of Hematopoietic Stem Cell Transplantation in Children
by: Koray Yalçın, et al.
Published: (2022-09-01) -
S242: EARLY INFUSION OF MSCS IN THE PROPHYLAXIS OF GVHD AFTER HAPLO-HEMATOPOIETIC STEM-CELL TRANSPLANTATION
by: R. Huang, et al.
Published: (2022-06-01) -
GVHD Prophylaxis 2020
by: Mahasweta Gooptu, et al.
Published: (2021-04-01) -
The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety
by: Xiaoli Chen, et al.
Published: (2021-09-01)